 | • レポートコード：MRC2303B069 • 出版社/出版日：Mordor Intelligence / 2023年3月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の市場調査書では、世界の傷跡治療市場規模が予測期間中（2022～2027年）に年平均9％上昇すると推測されています。本調査書では、傷跡治療の世界市場を広く調査・分析をし、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、瘢痕種類別（萎縮性瘢痕、肥厚性・ケロイド瘢痕、拘縮瘢痕、その他）分析、製品種類別（外用製品、レーザー製品、注射剤製品、その他）分析、エンドユーザー別（病院・診療所、小売ドラッグストア、Eコマースストア）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などを整理しています。また、本書には、Alliance Pharma、Bausch Health、Smith & Nephew plc、Merz Pharma GmbH & Co. KGaA、Lumenis、 Sonoma Pharmaceuticals, Inc.、Molnlycke Health Care、 Cynosure, Inc.、 Suneva Medical, Inc.、Sientra, Inc.などの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の傷跡治療市場規模：瘢痕種類別 - 萎縮性瘢痕における市場規模 - 肥厚性・ケロイド瘢痕における市場規模 - 拘縮瘢痕における市場規模 - その他瘢痕における市場規模 ・世界の傷跡治療市場規模：製品種類別 - 外用製品の市場規模 - レーザー製品の市場規模 - 注射剤製品の市場規模 - その他傷跡治療の市場規模 ・世界の傷跡治療市場規模：エンドユーザー別 - 病院・診療所における市場規模 - 小売ドラッグストアにおける市場規模 - Eコマースストアにおける市場規模 ・世界の傷跡治療市場規模：地域別 - 北米の傷跡治療市場規模 アメリカの傷跡治療市場規模 カナダの傷跡治療市場規模 メキシコの傷跡治療市場規模 … - ヨーロッパの傷跡治療市場規模 ドイツの傷跡治療市場規模 イギリスの傷跡治療市場規模 フランスの傷跡治療市場規模 … - アジア太平洋の傷跡治療市場規模 中国の傷跡治療市場規模 日本の傷跡治療市場規模 インドの傷跡治療市場規模 … - 南米/中東の傷跡治療市場規模 南アフリカの傷跡治療市場規模 ブラジルの傷跡治療市場規模 アルゼンチンの傷跡治療市場規模 … ・競争状況 ・市場機会・将来動向 |
Scar Treatment Market is believed to witness a CAGR of 9% over the forecast period (2022-2027).
The COVID-19 pandemic had a significant impact on the scar treatment market. During the pandemic, the e-commerce industry boomed drastically and people started relying more on online purchases of aesthetic products. This helped the e-commerce end users of the scar treatment market to keep a good pace in the pandemic. However, hospitals and retail drug stores faced a huge decline in the overall sale of products concerned with scar treatment. In addition, due to the lockdown in major countries, traveling declined during the year 2020-2021 which resulted in the declined number of road accidents and scars associated with the same. Therefore, it is observed that the scar treatment market has seen a significant decline in its value during the COVID-19 pandemic. However, with the pandemic in control and all healthcare services restarted, it is expected that the market will gain its pace rapidly in the short term.
Moreover, The market is majorly driven by the factors such as increasing road accidents and growing concerns of the general population about aesthetic appearance. As stated by the World Health Organization 2020 report, every year, the lives of more than 1.35 million people are cut short as a result of a road traffic crash. Between 20 and 50 million more people suffer non-fatal injuries, with many incurring a disability as a result of their injury. There have been continuous advancements in scar treatment technology. For instance, dermabrasion, CO2 laser, micro-needling, and microplasma technology are expected to witness wide adoption owing to their efficacy in scar treatment. Lately, the use of silicone sheets and steroid injections are also getting attention in scar treatment. Hence, such emerging technologies are expected to propel market growth in the future.
Major companies in the global market provide unique products that are approved by the United States Food and Drug Administration. For instance, Sientra, Inc. provides BIOCORNEUM which is the only advanced scar treatment with FDA-Cleared Silishield patented cross-linked medical grade silicone and SPF 30. With the presence of such advanced products, scar treatment has become easier. As a result, the market is growing.
Other driving factors for the market studied include technological advancements in skincare and growing concerns regarding aesthetic appearance, especially in developed markets. However, the high cost of laser-based products acts as a major barrier to the scar treatment market.
Scar Treatment Market Trends
Atrophic Scars to Witness Rapid Growth Over the Forecast Period
When the skin is unable to repair tissue, atrophic scars develop. As a result, it causes uneven scarring. Atrophic scars are primarily characterized by the sunken area often visible as pitted skin. Several factors may be responsible for creating atrophic scars in the skin, such as exposure to inflammatory conditions for a long period, accident, surgery, or other genetic factors. One of the corrective measures initially applied are gentle cleansing agents, moisturizers, and soaps, which are not harsh and irritant on the skin, but remove bacteria, dirt, and oil from the skin. The ice-pack scars represent 60-70% of atrophic scars, as stated by the report from AWD Supplies which is one of the well-known companies providing scar treatment solutions.
New techniques such as triple steps acne scar revision are proving to be effective in treating atrophic scars. In addition, there is a growing trend of aesthetic procedures across developing and developed countries, as suggested by the ISAPS (International Society for Aesthetic Plastic Surgery) data 2021.
When compared to other skin conditions, the atrophic scars are relatively common, wherein about 80% of the adolescent population are affected by it, to some degree, as per the National Institute of Health. The awareness level regarding this scar type is rather high, globally. Since atrophic scars are more common, the treatment for the same is being taken largely which is ultimately increasing the market size.
North America is the largest market for Scar Treatment
North America witnesses a significantly high number of road accidents. In such accidents, several die, and several are bruised for a long term, where scars occur as part of the healing process, naturally. According to the estimates of the Insurance Institute for Highway Safety (IIHS) and Highway Loss Data Institute (HLDI), in 2020 there were 35,165 motor vehicle crashes in the United States, in which around 38,824 deaths occurred.
A 2021 report from ISAPS stated that the United States is a country with the most non-surgical aesthetic procedures which accounted for around 3,182,815 as of 2020. This high number of aesthetic procedures also includes the treatments taken for scars which are boosting the market growth in the United States.
In North America, insurance is covered for several scar treatment products. The submission of a product as per the insurance codes listed for different types of scars and treatment options varies. However, in the case of laser treatment, since the therapy is considered a cosmetic procedure, most insurance companies do not cover the cost of the treatment. There are several procedures under cosmetic dermatology practices, such as soft tissue augmentation fillers, skin needling, and punch excision, which are popular in scar treatment.
Scar Treatment Market Competitor Analysis
The market is fragmented because of the presence of major market players and these players are focusing on research and development, market expansions, partnerships, mergers in order to experience stable growth. Some of the market players are Alliance Pharma., Bausch Health, Smith & Nephew plc, Merz, Inc., Lumenis, Sonoma Pharmaceuticals, Inc., Mölnlycke Health Care, Cynosure, Inc., Suneva Medical, Inc. and Sientra, Inc.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Road Accidents and Burn Injuries
4.2.2 Growing Concerns Regarding Aesthetics Appearances
4.3 Market Restraints
4.3.1 High Cost of Laser-based Products and Procedures
4.3.2 Reimbursement Issues
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Scar Type
5.1.1 Atrophic Scars
5.1.2 Hypertrophic and Keloid Scars
5.1.3 Contracture Scars
5.1.4 Others
5.2 By Product Type
5.2.1 Topical Product
5.2.1.1 Silicon Sheets
5.2.1.2 Creams
5.2.1.3 Gels
5.2.1.4 Other Topical Products
5.2.2 Laser Product
5.2.2.1 CO2 Laser
5.2.2.2 Pulse-dyed Laser
5.2.2.3 Other Laser Product
5.2.3 Injectable Product
5.2.4 Others
5.3 By End User
5.3.1 Hospitals/Clinics
5.3.2 Retail Drug Stores
5.3.3 E-commerce Stores
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Alliance Pharma
6.1.2 Bausch Health
6.1.3 Smith & Nephew plc
6.1.4 Merz Pharma GmbH & Co. KGaA
6.1.5 Lumenis
6.1.6 Sonoma Pharmaceuticals, Inc.
6.1.7 Molnlycke Health Care
6.1.8 Cynosure, Inc.
6.1.9 Suneva Medical, Inc.
6.1.10 Sientra, Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS